chrisvoncsefalvay/vaers-outcomes huggingface dataset:
skin paresthesia; nerve pain; Extreme fatigue; Chills; Body aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 14Apr2021 14:00 (Lot number: Ew0161) at the age of 44 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hashimoto's thyroiditis" (unspecified if ongoing), notes: Other medical history: Hashimoto's thyroiditis. The patient's concomitant medications were not reported. Past drug history included: Singulair, reaction(s): "Allergy: Singulair". Vaccination history included: Bnt162b2 (Product: COVID 19, Lot unknown: False, Dose number: 1 , dose product: COVID 19, dose brand: Pfizer , dose brand unknown: False, dose lot number: Ep6955, dose lot unknown: False, dose administration time: 01:30 PM, dose vaccine location: Right arm), administration date: 24Mar2021, when the patient was 44 years old, for COVID-19 immunisation. The following information was reported: FATIGUE (non-serious) with onset 15Apr2021 12:00, outcome "recovered" (Apr2021), described as "Extreme fatigue"; CHILLS (non-serious) with onset 15Apr2021 12:00, outcome "recovered" (Apr2021), described as "Chills"; PAIN (non-serious) with onset 15Apr2021 12:00, outcome "recovered" (Apr2021), described as "Body aches"; PARAESTHESIA (non-serious), outcome "unknown", described as "skin paresthesia"; NEURALGIA (non-serious), outcome "unknown", described as "nerve pain". The events "skin paresthesia" and "nerve pain" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of fatigue, chills, pain. Therapeutic measures were taken as a result of paraesthesia, neuralgia.  Additional Information: After the first 2 doses I had skin paresthesia/nerve pain So frequently I had to be tested for MS which was negative. There was no other vaccine taken in four weeks. After the booster toradol and steroid shots used as the treatment drug for the event skin paresthesia/nerve pain. hospital type facility vaccine. There was no covid prior vaccine. There was no covid tested post vaccination.  Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a medical assistant, referring to an unspecified number of patients of unknown genders and ages. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On an unknown date, the patients were vaccinated with improperly stored dose of VAQTA with lot # M027879 and expiration date of 24-JAN-2018 and lot # M036458 with expiration date on 02-MAR-2018 (strength, dose and route of administration were not reported) for prophylaxis, however no adverse effects were reported. It was reported that the vaccines were exposed to temperature of 12 Centigrade degrees (°C) range for a time frame of 24 hours. The temperature excursion was recorded by a data logger and the previous excursions were reported as 9°C to 25°C for 9 hours for the vaccines. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1704USA007701: US-009507513-1704USA014374: US-009507513-1704USA014372.
Menstruation started two weeks early (approximately one week after vaccine) and lasted for 14 days, varying between light and heavy throughout the two weeks. Also had high fever (reaching 103.8) for four days (starting two days after vaccination) which was reported, and a rash of purple spots across my chest, arms, and back started after fever stopped. Rash was not very bothersome, but alarming. Experienced frequent nausea and lightheadedness, but I also was experiencing those symptoms at the time due to my concussion. One week exactly after vaccination all symptoms were gone and no treatment was needed.
G1P0 at 37w1d with Estimated Date of Delivery: 11/26/23.  Patient had appointment in clinic specifically for RSV vaccination under a Nurse Only visit. Per order, vaccine was administered by this RN, without review of recent vaccine history. This RN was notified later that upon further review by a different RN, this patient had already received an RSV vaccine on 10/23/2023, and that the RSV administered on 11/01 was in error.
This case was reported by a physician via call center representative and described the occurrence of flank pain in a 50-year-old male patient who received SHINGRIX for prophylaxis. On 4th June 2018, the patient received SHINGRIX. In June 2018, 2 days after receiving SHINGRIX, the patient experienced flank pain and shingles. On an unknown date, the outcome of the flank pain and shingles were unknown. It was unknown if the reporter considered the flank pain and shingles to be related to SHINGRIX. Additional details were provided as follows: The health care professional reported that 2 to 3 days after vaccination, the patient developed left flank pain. One week later the patient developed shingles on his left flank described as a 3 by 6 cm lesion. The reporter had no other information about the lot number or expiration date.  The adverse event was collected via chat.
Patient was given adult 18 year old flu vaccine instead of pediatric fluzone for 17 year old. No reaction was noted. No treatment required.
Walked a few minutes after received vaccine, walked with son toward observation. Pt reports feeling hot, agitated, dizziness, nausea, placed on w/c to medical bay. Placed in gurney - had oatmeal for breakfast - states feeling HA/nausea. HA 8/10 dizzy 10/10, +room spinning. PERRL, slight diff to arouse. Unable to walk d/t dizziness/drowsiness. Alert to name, place, vaccination area. 0 difficulty breathing, able to answer questions, slower to respond. Similar s/x >1 year ago d/t stress related son went to ER, dc'ed from ED). Son reports feeling fatigue for past 2 months. Son reports heavy menstrual period stopped 2 months ago p son. BP 131/84; HR 70 RR 16; Sat 98% on RA.
Pressure in ears ever since vaccine, increasing in frequency over time. Mostly when seated but in motion (when driving in a car, on an exercise bike). Feels like I am in an airplane rising in height with pressure building in ears. Not debilitating in any way but the increasing frequency led me to want to report this.
Vomiting and diarrhea. Pt. had several episodes of vomiting and diarrhea which last 3-4 hours after vaccine given. Pt. did not have a reaction to 1st dose. Pt dis well over the weekend.
Patient stated there was no pain when receiving the injection.  About 2 hours later she experienced pain in her left arm from her shoulder to her elbow.  It was painful to lift her arm at that time.  She took 2 doses of Ibuprofen 800 mg which did help.  The pain began to lessen on 5/5/19.  On Monday when she reported this the pain was a little less.
SHARP PAIN IN BACK; COUGH; SORE THROAT (THAT'S GETTING WORSE); NASAL IRRITATION; This spontaneous report received from a patient concerned a 33 year old female. The patient's weight was 200 pounds, and height was 64 inches. The patient's concurrent conditions included: anxiety, cigarette smoker, non-alcohol user, depression, and attention deficit hyperactivity disorder (adhd), and other pre-existing medical conditions included: The patient had no known allergies. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 203A21A, and expiry: UNKNOWN) dose was not reported, administered on 20-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 03-AUG-2021, the patient experienced sore throat (that's getting worse). On 03-AUG-2021, the patient experienced nasal irritation. On 05-AUG-2021, Laboratory data included: SARS-CoV-2 RT-PCR test (NR: not provided) Negative, and SARS-CoV-2 rapid diagnostic test (NR: not provided) Negative. On 06-AUG-2021, the patient experienced cough. On 10-AUG-2021, the patient experienced sharp pain in back. On 14-AUG-2021, Laboratory data included: Chest X-ray (NR: not provided) Normal, and SARS-CoV-2 rapid diagnostic test (NR: not provided) Negative. Laboratory data (dates unspecified) included: Mononucleosis heterophile test (NR: not provided) Negative. Treatment medications (dates unspecified) included: azithromycin. The action taken with covid-19 vaccine was not applicable. The patient was recovering from nasal irritation, and cough, and had not recovered from sore throat (that's getting worse), and sharp pain in back. This report was non-serious.
Swollen and painful right upper arm, per patient symptoms appeared after receiving vaccine. Treated with BENADRYL and BACTRIM.
Since receiving vaccination, pt has had subjective intermittent fevers, persistent shortness of breath, dizziness, multiple joint pains, bodyaches and mild leg edema. Currently undergoing lab and imaging evaluation for many other possible causes
My first dose was taken 32 days back and COVID positive was 14 days back; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (My first dose was taken 32 days back and COVID positive was 14 days back) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, the patient experienced COVID-19 (My first dose was taken 32 days back and COVID positive was 14 days back). At the time of the report, COVID-19 (My first dose was taken 32 days back and COVID positive was 14 days back) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive and negative (Negative) after quarantine patient tested negative..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.  This is a regulatory authority case concerning  a  patient of unknown age and gender with no relevant medical history, who experienced the non-serious event Covid-19. The event occurred approximately 32 days after the first dose of mRNA-1273 COVID 19 Vaccine. The rechallenge was not applicable, as the event happened after the first dose. The event was reported as resolved. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.; Sender's Comments: This is a regulatory authority case concerning  a  patient of unknown age and gender with no relevant medical history, who experienced the non-serious event Covid-19. The event occurred approximately 32 days after the first dose of mRNA-1273 COVID 19 Vaccine. The rechallenge was not applicable, as the event happened after the first dose. The event was reported as resolved. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.
My face became red with tiny bumps; My face became red with tiny bumps; Hard chills; Headache; Body aches; I got up to bathroom & had to hold on to the wall because I was wobbly. On the way back to bed, when I let go of the wall, I fell backwards into the floor.; Temperature was 101.2 F; My arm where I had the injection is still sore to touch with itching.; My arm where I had the injection is still sore to touch with itching.; fell backwards into the floor; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female (not pregnant) patient received the third dose of BNT162B2 (PFIZER COVID-19) via an unspecified route of administration on the left arm on 27Oct2021 at 09: 15 (Batch/Lot Number: FH8027) at the age of 69-year-old as single dose for COVID-19 immunization. Medical history included hypertension, hypercholesterolemia, low thyroid, tachycardia, right knee replacement from Apr2021 and hysterectomy. The patient didn't received other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included levothyroxine sodium (SYNTHROID), lisinopril, vitamin c [ascorbic acid] and vitamin d3. The patient previously received the second dose and the first dose of BNT162B2, the second dose on 08Mar2021 at 09:30 AM (Batch/Lot No: EN6201), the first dose on 15Feb2021 at 09:15 AM (Batch/Lot Number: EN6201), both via an unspecified route of administration on the left arm at the age of 69-year-old as single dose for COVID-19 immunization. On 27Oct2021 at 09:15 AM, 2 hours after the vaccine, the patient's face became red with tiny bumps. That evening the patient started having hard chills, headache and body aches. During the night, the patient got up to bathroom and had to hold on to the wall because he was wobbly. On the way back to bed, when he let go of the wall, he fell backwards into the floor. The next day the temperature was 101.2 F. Continued with headache & body aches the next day. Her arm where he had the injection was still sore to touch with itching. Treatment was not received. The outcome of events was recovered in 2021.  No follow-up attempts are possible. No further information is expected.
Site: Bruising at Injection Site-Mild, Systemic: Other- Bells Palsy-Medium
Two days after the vaccine, on Saturday morning (3/13/2021), I started to feel pain when standing and walking.  The pain was in my shins and ankles.  Throughout the weekend (3/13/2021 - 3/14/2021), the pain increased in severity, and my calves plus ankles began to swell severely.  I remember weighing myself and being around 7 pounds heavier than usual.  On Monday (3/15/2021), I was able to visit my Primary Care Physician's office for an ad-hoc/emergency appointment.  Dr. diagnosed me with "bilateral feet swelling and ankle pain after he had his COVID vaccine".  She asked and acknowledged that no other change in behavior or "other specific aggravating or alleviating factors" would have caused this other than the COVID vaccine.  Dr. provided an "AMB REF to Orthopedic Surgeon", but they were unable to see me until Thursday (3/18/2021).  Therefore, the Dr. said I should go to the Emergency Room in case of blood clotting or DVT.  I followed her advice and went immediately to the suggested ER.  I was admitted to the ER on Monday (3/15/2021) afternoon and remained there through that evening.  They performed Doppler Ultrasound, Urine Analysis (UA), Complete Blood Count (CBC), and a Comprehensive Metabolic Panel (CMP), with "no significant findings".  DVT and Blood Clotting were ruled out after the extensive tests conducted.  The ER staff told me to elevate my legs as much as possible, and to wear compression socks up to my hips/thighs until the swelling subsided.  The ER staff also stated similarly to the Dr., that they believed this was an adverse reaction to the COVID vaccine.   On Thursday (3/18/2021), I was able to attend my appointment at the Orthopedic Clinic.  They performed "B/L foot XR" (x-rays), with the result of "no fx noted, no degenerative changes, no other structural changes noted."  Both the attending and the Medical Student assisting said it was likely due to the COVID vaccine.  They encouraged me to continue elevating and wearing compression socks until swelling plus pain subsided.  As suggested, I had a follow-up appointment with my Primary Care Physician's Office on Tuesday (4/6/2021) with the Dr. "reviewed ER records" and swelling was resolved by this date.  Dr. "advised to continue with the 2nd dose of the COVID vaccine".
She got her vaccine, no reaction to the arm, no arm pain, nothing.  Then that evening 3 hours later she could hardly walk when she stood up.  Her right side of her body starting from hip to inner thigh and stabbing pain in her groin area with any step she took.  Firing pain to her hip and inner thigh.  She was limping that evening and went to bed, and when she woke up with stabbing pain in her hip and groin area and unable to walk at all.  She had to scoop around in her office chair as she is OK to sit, but when she takes her first step on the right side has the stabbing pain until her body (warms) up for at least the first several steps at least.  She did go to her doctor and he prescribed Diclofenac sodium 75 mg twice daily for the inflammation and should go away within a week or two, but it has been almost a month and the symptoms have not gone away.  Her hip area has gotten much better, however, her groin area has gotten worse.  It's at the point that she can walk, but she grimaces and hurts once she's able to get up and walk.  In the right groin she can distinctly feel the sharp stabbing pain as she walks.  Again, as long as she's sitting she is okay, but upon trying to walk the first 5-6 steps it is painful.  The longer she walks the pain diminishes more.  She did not have these symptoms prior to the vaccine.   She did not fall or do anything to injure herself.  She is now going to restart taking the medication he prescribed to her.    First vaccine had foot pain on the right side that went away by the next day.
This case was reported by a nurse and described the occurrence of incorrect storage of drug in a patient who received PEDIARIX (batch number 4233K, expiry date 6th September 2016). On an unknown date, the patient received PEDIARIX. On an unknown date, an unknown time after receiving PEDIARIX, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. Additional information: Nurse at this time did not have any other information. Ten patients received BOOSTRIX that was exposed to temperature of 30.4F. Two lot numbers 3P9CL exp 15Apr2016 or HM4FY exp 06Dec2016.
Approximately 30  minutes after receiving his injection  he returned to the site complaining that he experienced a " split second second of dizziness and became light headed and had a tingling sensation to his left arm (the arm that he received the vaccine in.)" right after he left.   He said it came and left quickly.  He said the symptoms were gone and he felt fine and then he felt the symptoms again while nurse was checking his b/p.  Those symptoms left quickly as well.  EMS came to evaluate the patient.
fever, chills, loss of appetite, fatique  frequent stools  for 36 hours
1) threw up 3x at 8 pm the night of the injection (4/7/21). Felt malice for 48 hours afterwards.  2) heavier than normal period (blood clots coming out). Cycle started on 4/11 which is my expected timing.
pt stated exp local rxn to 1st vax p/ 2 days approx 4" reddish/brown mark noted @ site w/moderate swelling;no fever or systemic rxn noted;rxn described as moderate rxn & requested 2nd varicella be given;
sore throat; dizziness; high blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HYPERTENSION (high blood pressure) and OROPHARYNGEAL PAIN (sore throat) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced DIZZINESS (dizziness) and HYPERTENSION (high blood pressure). On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat). At the time of the report, DIZZINESS (dizziness), HYPERTENSION (high blood pressure) and OROPHARYNGEAL PAIN (sore throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Platelets dropped; Could not get out of bed; Arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of PLATELET COUNT DECREASED, FATIGUE (Could not get out of bed), and VACCINATION SITE PAIN in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included Platelets increased since an unknown date. Concurrent medical conditions included Platelets decreased. Concomitant products included HYDROXYUREA for Platelet count low, VITAMIN D, VITAMIN B COMPLEX, PRESERVISION AREDS 2, BABY ASPIRIN, and ATORVASTATIN for an unknown indication.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PLATELET COUNT DECREASED, FATIGUE (Could not get out of bed), and VACCINATION SITE PAIN. At the time of the report, PLATELET COUNT DECREASED, FATIGUE (Could not get out of bed), and VACCINATION SITE PAIN outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Platelet count: 406.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
erythema, ecchymosis, pain & edema @ inject site are reported in a pt who recvd flu vax; above sx occurred 12 hrs p/vax given & resolved w/in 48 hrs;
About 20-30 minutes after receiving the vaccine, the patient began feeling weakness in the legs/saying unable to walk. We checked all vitals and those were normal. 911 was called and ambulance came. The patient was able to walk out to the ambulance  saying his symptoms had subsided and get checked by emergency personal. After being checked by emergency personal and all vitals being good/symptoms subsiding the patient decided he was fine to go home.  After being home for sometime, the patient's wife stated that he started losing vision in left eye. They consulted with a doctor and were told to go to the hospital. The patient's wife stated that he was admitted and several tests were done to check for blockage/or stroke. All tests are coming back normal. The patient is remaining in hospital for more tests to be done. Unknown if this was caused by either vaccine.
delayed hypersensitivity rxn lt arm;entire area from shoulder to elbow markedly red, swollen & warm;lasted 3-4d;no tx required other than APAP & cool compresses;
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 14-OCT-2013, the patient was inoculated with the ZOSTAVAX vaccine as recommended for routine adult health maintenance for prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 05-OCT-2016, the patient was treated for a blistering vesicular outbreak that was diagnosed as severe herpes zoster. The patient was prescribed famciclovir for management of his painful symptoms and chronic pain. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.